Summary & Overview
HCPCS C1888: Implantable Endovascular Catheter for Non-Cardiac Ablation
HCPCS Level II code C1888 denotes an implantable endovascular catheter used for non-cardiac ablation procedures. This device-level code is important for billing and coverage of minimally invasive ablation therapies that target non-cardiac vascular or perivascular tissues. As device-based interventions expand, clear coding for implantable ablation catheters supports accurate claims processing, durable medical equipment classification, and device tracking across care settings.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage patterns, reimbursement benchmarks where available, and common clinical contexts in which C1888 is billed.
Readers will find a concise overview of the clinical role of the device, expected sites of service (hospital outpatient departments, ambulatory surgical centers, and inpatient operating rooms), typical billing considerations, and the landscape of payer policies affecting coverage and payment. Where specific payer policies or national pricing benchmarks are not provided in the input, the report notes that data is not available in the input. The goal is to provide a national-level reference for clinicians, coding professionals, and policy analysts on the use and billing of HCPCS Level II code C1888.
Billing Code Overview
HCPCS Level II code C1888 describes an implantable, endovascular catheter used for non-cardiac ablation procedures. The code represents a medical device intended for vascular access and delivery of energy or agents to ablate non-cardiac tissue via endovascular techniques.
Service Type: Device implantation for endovascular ablation (non-cardiac)
Typical Site of Service: Hospital outpatient department, ambulatory surgical center, or inpatient operating room, depending on clinical setting and procedure complexity.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with recurrent symptomatic focal venous malformation in the thigh is evaluated by an interventional radiology team for catheter-directed endovascular ablation therapy. Prior conservative measures including compression and sclerotherapy provided incomplete symptom control. The patient undergoes pre-procedure assessment including focused history, anticoagulation review, coagulation studies, and consent for an implantable non-cardiac ablation catheter. In the angiography suite (typical site of service: hospital outpatient department or ambulatory surgery center), ultrasound and fluoroscopic guidance are used to access the target vessel percutaneously. The implantable endovascular ablation catheter (C1888) is positioned within the target venous channel and activated to deliver thermal or energy-based ablation to occlude the lesion. Peri-procedural monitoring includes hemodynamic observation, pain control, and imaging confirmation of lesion closure. Post-procedure workflow includes recovery observation, discharge instructions for wound care and activity restrictions, scheduling of follow-up imaging, and documentation of device implantation details (device model, lot, and implant location). Typical providers involved include interventional radiologists, vascular surgeons, and procedural nursing staff.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |